Selenomethionine protects against adverse biological effects induced by space radiation

Free Radical Biology and Medicine

Volumn 36, Issue 2, 2004, Pages 259-266

  Kennedy, Ann R ^a,c   Ware, Jeffrey H ^a   Guan, Jun ^a   Donahue, Jeremiah J ^a   Biaglow, John E ^a   Zhou, Zhaozong ^a   Stewart, Jelena ^a   Vazquez, Marcelo ^b   Wan, X Steven ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c 195 John Morgan Building ^*  (United States)

Author keywords

Free radicals; HZE particles; Oxidative stress; Selenomethionine

Indexed keywords

ANTIOXIDANT; CHECKPOINT KINASE 2; DNA; SELENOMETHIONINE;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; COSMIC RADIATION; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; NONHUMAN; OXIDATIVE STRESS; PARTICLE RADIATION; PRIORITY JOURNAL; RAT; RAT STRAIN; THYROID CELL;

EID: 1642464707     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.10.010     Document Type: Article

References (39)

1. Sies H. Oxidative stress. 1985;Academic Press, New York.
2. Miura Y., Ozawa T. Noninvasive study of radiation-induced oxidative damage using in vivo electron spin resonance. Free Radic. Biol. Med. 28:2000;854-859.
3. Shin S.J., Yamada K., Sugisawa A., Saito K., Miyajima T., Umegaki K. Enhanced oxidative damage induced by total body irradiation in mice fed a low protein diet. Int. J. Radiat. Biol. 78:2002;425-432.
4. Agrawal A., Chandra D., Kale R.K. Radiation induced oxidative stress: Ii studies in liver as a distant organ of tumor bearing mice. Mol. Cell. Biochem. 224:2001;9-17.
5. Stein T.P., Leskiw M.J. Oxidant damage during and after spaceflight. Am. J. Physiol. Endocrinol. Metab. 278:2000;E375-E382.
6. Ross J.S., Stagliano N.E., Donovan M.J., Breitbart R.E., Ginsburg G.S. Atherosclerosis: a cancer of the blood vessels? Am. J. Clin. Pathol. 116:2001;S97-S107.
7. Witztum J.L., Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc. Med. 11:2001;93-102.
8. Kovacic P., Jacintho J.D. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr. Med. Chem. 8:2001;773-796.
9. Ambrosone C.B. Oxidants and antioxidants in breast cancer. Antioxidants Redox Signaling. 2:2000;903-917.
10. Poulsen H.E., Prieme H., Loft S. Role of oxidative DNA damage in cancer initiation and promotion. Eur. J. Cancer Prev. 7:1998;9-16.
11. Jenner P. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathol. Biol. 44:1996;57-64.
12. Drukarch B., van Muiswinkel F.L. Neuroprotection for Parkinson's disease: a new approach for a new millennium. Expert Opin. Invest. Drugs. 10:2001;1855-1868.
13. Aliev G., Smith M.A., Seyidov D., Neal M.L., Lamb B.T., Nunomura A., Gasimov E.K., Vinters H.V., Perry G., LaManna J.C., Friedland R.P. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol. 12:2002;21-35.
14. Tuppo E.E., Forman L.J. Free radical oxidative damage and Alzheimer's disease. J. Am. Osteopathic Assoc. 101:2001;S11-S15.
15. Combs G.F.J. Chemopreventive mechanisms of selenium. Med. Klin. 94(Suppl. 3):1999;18-24.
16. Reddy B.S., Rivenson A., El-Bayoumy K., Upadhyaya P., Pittman B., Rao C.V. Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets. J. Natl. Cancer Inst. 89:1997;506-512.
17. Nelson M.A., Porterfield B.W., Jacobs E.T., Clark L.C. Selenium and prostate cancer prevention. Semin. Urol. Oncol. 17:1999;91-96.
18. Khuri F.R., Lippman S.M. Lung cancer chemoprevention. Semin. Surg Oncol. 19:2000;100-105.
19. Clark L.C., Combs G.F. Jr., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher J.L. Jr., Park H.K., Sanders B.B. Jr., Smith C.L., Taylor J.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA. 276:1996;1957-1963.
20. Li J.Y., Taylor P.R., Li B., Dawsey S., Wang G.Q., Ershow A.G., Guo W., Liu S.F., Yang C.S., Shen Q., Wang W., Mark S.D., Zou X.N., Greenwald P., Wu Y.P., Blot W.J. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J. Natl. Cancer Inst. 85:1993;1492-1498.
21. Soule H.D., Vazguez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1973;1409-1416.
22. Lemoine N.R., Mayall E.S., Jones T., Sheer D., McDermid S., Kendall-Taylor P., Wynford-Thomas D. Characteristics of human thyroid epithelial cells immortalized in vitro by simian virus 40 DNA transfection. Bri. J. Cancer. 60:1989;897-903.
23. Wan X.S., Zhou Z., Kennedy A.R. Adaptation of the dichlorofluorescein assay for detection of radiation induced oxidative stress in cultured cells. Radiat. Res. 2003;. In Press.
24. Casarett A.P. Radiation biology. 1968;Prentice-Hall, Englewood, NJ.
25. Smith S.M., Davis-Street J.E., Rice B.L., Nillen J.L., Gillman P.L., Block G. Nutritional status assessment in semiclosed environments: ground-based and space flight studies in humans. J. Nutr. 131:2001;2053-2061.
26. Riches A.G., Herceg Z., Bryant P.E., Wynford-Thomas D. Radiation-induced transformation of sv40-immortalized human thyroid epithelial cells by single and fractionated exposure to γ-irradiation in vitro. Int. J. Radiat. Biol. 66:1994;757-765.
27. Riches A.C., Herceg Z., Bryant P.E., Stevens D.L., Goodhead D.T. Radiation-induced transformation of sv40-immortalized human thyroid epithelial cells by single exposure to plutonium alpha-particles in vitro. Int. J. Radiat. Biol. 72:1997;515-521.
28. Klein E.A., Thompson I.M., Lippman S.M., Goodman P.J., Albanes D., Taylor P.R., Coltman C. Select: the next prostate cancer prevention trial. Selenum and vitamin E cancer prevention trial. J. Urol. 166:2001;1311-1315.
29. Wilber C.G. Toxicology of selenium: a review. Clin. Toxicol. 17:1980;171-230.
30. NCI DCPC Chemoprevention Branch and Agent Development Committee Clinical Development Plan: l-selenomethionine. J. Cell. Biochem. 26S:1996;202-218.
31. Michiels C., Raes M., Toussaint O., Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-sod for cell survival against oxidative stress. Free Radic. Biol. Med. 17:1994;235-248.
32. Mustacich D., Powis G. Thioredoxin reductase. Biochem. J. 346:2000;1-8.
33. Hall E.J. Radiobiology for the radiologist. 5th ed. 2000;Lippincott Williams & Wilkins, Philadelphia.
34. Seo Y.R., Kelley M.R., Smith M.L. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc. Natl. Acad. Sci. USA. 99:2002;14548-14553.
35. Durocher D., Jackson S.P. DNA-pk, atm and atr as sensors of DNA damage: variations on a theme? Curr. Opin. Cell Biol. 13:2001;225-231.
36. Xu J., Xin S., Du W. Drosophila chk2 is required for DNA damage-mediated cell cycle arrest and apoptosis. FEBS Lett. 508:2001;394-398.
37. Hirao A., Cheung A., Duncan G., Girard P.M., Elia A.J., Wakeham A., Okada H., Sarkissian T., Wong J.A., Sakai T., De Stanchina E., Bristow R.G., Suda T., Lowe S.W., Jeggo P.A., Elledge S.J., Mak T.W. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (atm)-dependent and an atm-independent manner. Mol. Cell. Biol. 22:2002;6521-6532.
38. Cliby W.A., Roberts C.J., Cimprich K.A., Stringer C.M., Lamb J.R., Schreiber S.L., Friend S.H. Overexpression of a kinase-inactive atr protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17:1998;159-169.
39. Bartek J., Falck J., Lukas J. Chk2 kinase: a busy messenger. Nat. Rev. Mol. Cell Biol. 2:2001;877-886.